Background & Purpose

Sweden needs a reliable manufacturing preparedness to ensure access to critical medicines during peacetime crises, heightened states of alert, and war.

Proposals & Debate

The government proposed an extra amendment budget allowing a capital contribution of up to 700 million SEK to the state-owned company APL. This funding enables APL to swiftly acquire a specific manufacturing operation to safeguard the national medicine supply.

The Decision

The Swedish parliament voted in favor of the government's proposal, granting a capital injection of up to 700 million SEK to APL during 2025.

Does this affect you?

  • Patients in Sweden: Gets improved security of supply for critical and life-saving medicines during potential crises.
  • State-owned enterprises: APL receives substantial financial support to expand its manufacturing operations.

In Practice

  • APL receives up to 700 million SEK in capital from the state during 2025.
  • APL uses the funds to purchase a manufacturing operation focused on critical medicines.
  • Sweden's preparedness and capability to produce vital drugs domestically during crises are strengthened.